6304p UNIVERSITY OF WASHINGTON DEPARTMENT OF MEDICINE DIVISION OF ONCOLOGY Protocol 118 Phase I/II Study of Combination Immunotherapy for the Generation of HER -2/neu (HER2) Specific Cytotoxic T Cells (CTL) in vivo Current Version Date: 04/06/2016 Previous Version Date: 11/ 14/2006 Investigators: Researchers: Mary L. Disis, M.D.